Swedish Biotech Alzecure Lands Two Record Licensing Deals

Alzecure Pharma, a twelve-employee Swedish biotech, secured two of the largest licensing deals in Swedish biotech history this summer. The deals signal strong commercial interest in its pipeline, though financial terms and partner identities remain undisclosed. This highlights continued M&A and licensing activity in the biotech sector, which could have positive implications for the sector's risk appetite.